Previous 10 | Next 10 |
A potential purchase of Rite Aid (NYSE:RAD) by a relatively unknown activist investment firm doesn't make sense, according to a Deutsche Bank analyst, who recently cut the drugstore chain to a sell rating. Rite Aid (RAD) shares surged earlier, though they pared gains to 11%, after a NYP...
Update: Updates share price. Rite Aid (NYSE:RAD) pared more than half of its earlier gains, now up 12% after earlier jumping 32%, on a report that the drugstore chain rejected a bid for $14.60/share, or $815 million. Rite Aid rejected an offer from Spear Point Capital...
Rite Aid (NYSE:RAD) soared 32% after report that Rite Aid rejected a bid for $14.60/share, or $815 million, earlier this month. Rite Aid rejected an offer from Spear Capital Management, according to a NYPost report. Developing story ... For further details see: Rite Aid jumps ...
Are These The Best Health Care Stocks To Buy As Pandemic Conditions Worsen? Between an increasingly aggressive Fed interest rate hike plan, ongoing pandemic conditions, and inflation, the stock market is under pressure. As a result of all this, investors could be turning their a...
Image source: The Motley Fool. Rite Aid (NYSE: RAD) Q4 2022 Earnings Call Apr 14, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Rite Aid (RAD) Q4 2022 Earnings Call Transcript
Rite Aid Corporation (RAD) Q4 2022 Earnings Conference Call April 14, 2022 8:30 AM ET Company Participants Byron Purcell - Investor Relations Heyward Donigan - President & CEO Matt Schroeder - EVP & CFO Andre Persaud - EVP & CRO, Elixir Chris DuPaul - COO, Elixir Conference Call P...
The following slide deck was published by Rite Aid Corporation in conjunction with their 2022 Q4 earnings call. For further details see: Rite Aid Corporation 2022 Q4 - Results - Earnings Call Presentation
Shares of Rite Aid (NYSE: RAD) had plunged 49% as of the market close on Wednesday. However, the pharmacy stock was rebounding by 5.3% as of 11 a.m. ET on Thursday and had risen as much as 21.5% earlier in the day. Investors cheered Rite Aid's fourth-quarter update, which was announ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Palantir Technologies (NYSE: PLTR ) stock is getting ready for a catalyst that investors will want to watch out for on April 27. Source: Spyro the Dragon / Shutterstock.com That’s when the tech company ...
Rite Aid (RAD +7.6%) shows Q4 revenue of $6.06M, beats consensus by $110M. Bifurcating revenue: pharmacy services segment $1.7B (-9.4% Y/Y); pharmacy services segment $7.3B (-8.1% Y/Y) Q4 net loss from continuing operations of $389.1M, or EPS loss of $7.18; adjusted net loss from co...
News, Short Squeeze, Breakout and More Instantly...
Secures Interim Approval to Access Up to $3.45 Billion in Debtor-in-Possession Financing Continues to Serve Customers and Deliver Healthcare Products and Services Across Retail and Online Platforms Rite Aid Corporation (OTC: RADCQ) (“Rite Aid” or the “Compan...
Stein Succeeds Elizabeth “Busy” Burr Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) today announced that its Board of Directors has appointed Jeffrey S. Stein as Chief Executive Officer (CEO), Chief Restructuring Officer (CRO) an...
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan Initiates Voluntary Chapter 11 Process to Implement a Consensual Financial Restructuring That Will Significantly Reduce Debt and Enable Execution of Key Initiatives Receives Commitment f...